"We are convinced that Nanolive's disruptive technology will make a significant contribution to the improvement of human health. The software used enables 3D scans to be displayed in real time on all digital devices. This means new discoveries can be shared with other researchers very quickly," reports Roger Wüthrich-Hasenböhler, Head of Swisscom Digital Business, from the Silicon Valley. Dominique Mégret, Head of Swisscom Ventures, adds, "with our investment, we want to help move the Swiss startup ecosystem forward. Nanolive represents a good example of linking pioneering technologies such as nanotechnology, biotechnology and medical informatics, which is relevant for Swisscom in the areas of Smart Data and Cloud Services."